Steve Granger, Ph.D.
Dr. Granger is a highly experienced molecular immunologist with a strong track record in pre-clinical drug development and over a decade of expertise in salivary diagnostics.
As the Chief Scientific Officer, Dr. Granger leads the research and development efforts to advance saliva and dried blood spot (DBS) testing. Under his leadership, Salimetrics has expanded its capabilities from biobehavioral research to include markers of infectious disease, inflammation, cardiometabolic health and circadian physiology. Dr. Granger’s more recent contributions include at-home collected methods for circadian melatonin profiling, Dim Light Melatonin Onset (DLMO), that can be combined with cortisol testing to help improve sleep and stress management. He has also contributed to the launch of direct-to-consumer health tests like a dried blood spot CRP testing, dried salivary insulin and introduced specialized melatonin tests for parents and children.
With a keen interest in innovation, his work is pivotal in aligning the right sampling methods with the specific needs of various research questions, participant demographics, and budget constraints.